Indoleamine 2,3-dioxygenase in tumor induced tolerance

被引:18
|
作者
Liu Xiao-qian [1 ]
Wang Xin [1 ]
机构
[1] Shandong Univ, Dept Hematol, Prov Hosp, Jinan 250021, Shandong, Peoples R China
关键词
indoleamine 2,3-dioxygenase; immune tolerance; dendritic cells; regulatory T cells; 1-methyl-tryptophan; REGULATORY T-CELLS; PLASMACYTOID DENDRITIC CELLS; DRAINING LYMPH-NODES; TRYPTOPHAN CATABOLISM; BACTERIAL LIPOPOLYSACCHARIDE; INCREASED POPULATIONS; PERIPHERAL-BLOOD; IDO; INHIBITION; EXPRESSION;
D O I
10.3760/cma.j.issn.0366-6999.2009.24.030
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective To review the recent studies about the role of indoleamine 2,3-dioxygenase (IDO) in tumor induced tolerance. Data sources Published articles (1978-2009) on IDO and tumor induced tolerance were selected from Medline. Study selection Articles selected were relevant to development of IDO in tumor induced tolerance. Of all originally identified articles, 50 specially addressed the stated purpose. Results Recent work has revealed IDO at high levels in tumors and in tumor-draining lymph nodes and a close relationship between IDO activity and the regulatory T cells. Conclusion Up-regulation of IDO is proven to be a mechanism of acquired tolerance in tumors, in which the closely coupled positive feedback system between IDO and regulatory T cells may be considered to play an important role. Chin Med J 2009,122(24):3072-3077
引用
收藏
页码:3072 / 3077
页数:6
相关论文
共 50 条
  • [1] Indoleamine 2,3-dioxygenase, Tregs and Cancer
    Munn, D. H.
    CURRENT MEDICINAL CHEMISTRY, 2011, 18 (15) : 2240 - 2246
  • [2] Host Indoleamine 2,3-Dioxygenase: Contribution to Systemic Acquired Tumor Tolerance
    Johnson, Theodore S.
    Munn, David H.
    IMMUNOLOGICAL INVESTIGATIONS, 2012, 41 (6-7) : 765 - 797
  • [3] Indoleamine 2,3-Dioxygenase and Dendritic Cell Tolerogenicity
    Harden, Jamie L.
    Egilmez, Nejat K.
    IMMUNOLOGICAL INVESTIGATIONS, 2012, 41 (6-7) : 738 - 764
  • [4] Indoleamine 2,3-dioxygenase and immune tolerance in ovarian cancer
    Ino, Kazuhiko
    CURRENT OPINION IN OBSTETRICS & GYNECOLOGY, 2011, 23 (01) : 13 - 18
  • [5] The Role of Indoleamine 2,3-Dioxygenase in Diethylnitrosamine-Induced Liver Carcinogenesis
    Shibata, Yuhei
    Hara, Takeshi
    Nagano, Junji
    Nakamura, Nobuhiko
    Ohno, Tomohiko
    Ninomiya, Soranobu
    Ito, Hiroyasu
    Tanaka, Takuji
    Saito, Kuniaki
    Seishima, Mitsuru
    Shimizu, Masahito
    Moriwaki, Hisataka
    Tsurumi, Hisashi
    PLOS ONE, 2016, 11 (01):
  • [6] Indoleamine 2,3-Dioxygenase Is It an Immune Suppressor?
    Soliman, Hatem
    Mediavilla-Varela, Melanie
    Antonia, Scott
    CANCER JOURNAL, 2010, 16 (04) : 354 - 359
  • [7] Indoleamine 2,3-Dioxygenase in Intestinal Immunity and Inflammation
    Cherayil, Bobby J.
    INFLAMMATORY BOWEL DISEASES, 2009, 15 (09) : 1391 - 1396
  • [8] Indoleamine 2,3-dioxygenase (IDO): Biology and Target in Cancer Immunotherapies
    Selvan, Senthamil R.
    Dowling, John P.
    Kelly, William K.
    Lin, Jianqing
    CURRENT CANCER DRUG TARGETS, 2016, 16 (09) : 755 - 764
  • [9] The role of indoleamine 2,3-dioxygenase in the induction of immune tolerance: focus on hematology
    Curti, Antonio
    Trabanelli, Sara
    Salvestrini, Valentina
    Baccarani, Michele
    Lemoli, Roberto M.
    BLOOD, 2009, 113 (11) : 2394 - 2401
  • [10] Tumor immune escape mediated by indoleamine 2,3-dioxygenase
    Zamanakou, Maria
    Germenis, Anastasios E.
    Karanikas, Vaios
    IMMUNOLOGY LETTERS, 2007, 111 (02) : 69 - 75